Genpact Wins Contract from AstraZeneca to Provide Global Finance & Accounting Services

Five-Year Multi Million Dollar Contract will Deliver Services to over 50 Countries 

NEW YORK and GURGAON--Genpact (NYSE: G), a leader in managing business processes, today announced it has signed a five-year contract to provide global Finance & Accounting (F&A) services to AstraZeneca, one of the world's leading pharmaceutical companies. Under the terms of the contract, skilled Genpact professionals will work in partnership with the company's finance team to boost the effectiveness of some of AstraZeneca's finance and accounting processes as part of the company's corporate initiative to reduce costs. The multi-million dollar contract will deliver services to over 50 countries.

Commenting on the partnership Graham Russell, Head of Global Transactional Finance AstraZeneca, said, "Streamlining our business processes will enable us to improve the effectiveness of AstraZeneca's finance function in driving, measuring and reporting business performance, while simultaneously reducing the costs of the finance function."

Genpact's F&A practice currently supports more than 80 global enterprises, including five pharmaceutical and two life sciences companies. The partnership with AstraZeneca will further expand Genpact's client base and broaden its experience in the Life Sciences industry. Leveraging best practices developed through more than a decade of experience in F&A services, Genpact's F&A experts will provide AstraZeneca with support in a range of areas including procure-to-pay, record-to-report and order-to-cash services. AstraZeneca conducted a competitive search before selecting Genpact.

"We are delighted to be chosen by AstraZeneca to streamline their Finance & Accounting operations," said Pramod Bhasin, Genpact's President & CEO. "Our granular knowledge of process, deep insights from handling over 3,000 business processes, global best practices and Lean Six Sigma tools will allow us to contribute substantially to improving the effectiveness of AstraZeneca's F&A operations and I look forward to an enduring and productive relationship," he added.

About Genpact
Genpact is a leader in managing business processes, offering a broad portfolio of enterprise and industry-specific services. The Company puts process in the forefront, coupling its deep process domain knowledge and insights with focused IT capabilities, targeted analytics and pragmatic reengineering to deliver comprehensive solutions for clients. The Company's culture is uniquely ingrained in Lean and Six Sigma and views process management as a science. Genpact has significantly invested in and developed the first scientific approach to process management, known as Smart Enterprise Processes (SEPSM), which focuses on optimizing process effectiveness in addition to efficiency to deliver superior business outcomes. Genpact seamlessly delivers services from a global network of centers to meet a client's business objectives, cultural and language needs and cost reduction goals. Genpact manages over 3,000 processes for over 175 clients worldwide.

Anita Trehan (Genpact Media Relations)
+91 (98) 1110 0223
anita.trehan@genpact.com

or

Sadaf Khan (For Genpact - India)
+91 (98) 9930 9389
sadaf.khan@bm.com

or

Melyn McKay Heckelman (For Genpact)
+1 (415) 677 274
Melyn.McKayHeckelman@ogilvypr.com